LEI 529900U66OBYQZG51E83
MILLIPORE
Group parent: E. Merck KG
Contract awards & public grants
From Insightful Science to Innovative Health: Strengthening Translational Capacity and Talent Interoperability in Vaccine and Biologic Research & inno → MILLIPORE SAS
European Commission · FR · Grant · 2023-07-04
—
ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2 → MILLIPORE SAS
European Commission · FR · Grant · 2021-11-15
€2.59M
Next-generation biopharmaceutical downstream process → MILLIPORE SAS
European Commission · FR · Grant · 2015-02-11
€1.7M
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.